Skip to main content

AngiNOX Orange 30

(No reviews yet)

Effervescent Nitric Oxide Formula

Card Subtitle:
Effervescent Nitric Oxide Formula
Product Subtitle:
Effervescent Nitric Oxide Formula

Product Overview

AngiNOX™ Orange

AngiNOX™ is XYMOGEN’s exciting formula based on the latest Nobel Prize-winning research on nitric oxide, a naturally occurring compound in the body. Nitric oxide is an important messenger that signals a variety of responses at the cellular level which are beneficial to circulatory, immune, and nervous system functions. AngiNOX is a refreshing, effervescent powder that offers therapeutic levels of L-arginine and L-citrulline, two amino acids the body uses to make nitric oxide.*

*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Suggested Use

Pour one level scoop of powder into a tall, empty glass. Add 3 oz of chilled water and lightly stir. Let stand one minute. Add 3 more oz of chilled water and lightly stir. Let stand one minute and drink. Take once daily, or as directed by your healthcare professional.

Consult your healthcare professional prior to use. Individuals taking medication should discuss potential interactions with their healthcare professional. Do not use if tamper seal is damaged.


Do NOT use if you have low blood pressure.

Supplement Facts

Serving Size: 1 Scoop (about 8 g)
Servings Per Container: 30

  Amount Per Serving % Daily Value
Calories 20  
Total Carbohydrate 3 g 1%†
Vitamin C (ascorbic acid) 300 mg 333%
Folate 3,400 mcg DFE (2,000 mcg folic acid) 850%
Sodium (as sodium bicarbonate) 220 mg 10%
L-Arginine 2 g **
L-Citrulline 500 mg **
Quercetin (as quercetin dihydrate) 500 mg **
Mixed Tocopherols 240 mg **
†Percent Daily Values are based on a 2,000 calorie diet.
**Daily Value not established.

Other Ingredients: Citric acid, dried cane syrup, natural orange flavor (no MSG), silica, and stevia leaf extract.

Made in a GMP compliant facility.



No reviews yet.